KIORA PHARMACEUTICALS INC business relationships
Companies named in KIORA PHARMACEUTICALS INC’s 10-K filed 2026-03-25, and public companies whose annual reports name KIORA PHARMACEUTICALS INC. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 72 / 100 Top 2% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in KIORA PHARMACEUTICALS INC’s annual report 0
No company named in this filing matched a company in the map.
Companies whose annual reports name KIORA PHARMACEUTICALS INC 1
“Hoffmann-La Roche AG ("Roche AG"), Kiora Pharmaceuticals, Inc., Genentech, Inc. in partnership with Lineage Cell Therapeutics, Inc., and Luxturna, the product developed by Spark Therapeutics, Inc. and marketed by Roche AG, is currently the only gene therapy approved to treat IRDs in the United State...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.